Latisse

Not enough lashes? Latisse grows lashes longer, fuller and darker.

LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker.

There's been a growing interest in this product ever since it was introduced. And it's no wonder. LATISSE® is the first FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker. Discover the LATISSE® difference.

LATISSE® solution is a growth treatment for hypotrichosis (inadequate or not enough eyelashes). In fact, it's the first FDA-approved treatment clinically proven to grow lashes. And it's the first lash growth product of its kind available by prescription. So you'll need to talk to your doctor to see if it's right for you.

LATISSE® grows lashes longer, fuller and darker.

LATISSE® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It's not an illusion of growth. It's real lash growth.

 

Does it work? How long does it take to see results?
LATISSE® is FDA approved and effective. It’s a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12 to 16 weeks.

Are there any side effects?
The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE®solution may cause other less common side effects which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.

LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. Refer to the illustration below. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE® under the close supervision of your physician.

What will happen if I stop using LATISSE® ?

If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.

Could Latisse cause the color of my eyes to change?
Increased brown iris pigmentation has occurred when the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure/glaucoma. Although iris pigmentation was not reported in clinical studies with LATISSE®, patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent.

How LATISSE® works.

LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.

The history behind LATISSE®.

LATISSE® was created by Allergan. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication's active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December of 2008.

 
 

Before and After Photos

Drop in or call in to check if we have your favorite in stock

CALL TODAY!